NCT01269866
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +7 more
- Locations
-
- Brain Resource Center New York, United States
Clinical trial condition
Lupus Erythematosus, Systemic
Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.
840 public trials
218 recruiting studies
Lupus Erythematosus, Systemic trial results
Completed
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
NCT01093911
- Conditions
- Autoimmune Diseases, Connective Tissue Disease, Connective Tissue Diseases, +3 more
- Locations
-
- 6 Leuven, Belgium
- 9 Sofia, Bulgaria
- 1 Berlin, Germany
- 2 Erlangen, Germany
NCT01206569
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
- Locations
-
- Prince of Wales Hospital Shatin, Hong Kong
NCT01702740
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +4 more
- Locations
-
Not specified
NCT00383513
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- Birmingham, Alabama, United States
- Tucson, Arizona, United States
- Los Angeles, California, United States
- Upland, California, United States
NCT00660881
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- Birmingham, Alabama, United States
- Tucson, Arizona, United States
- La Jolla, California, United States
- Los Angeles, California, United States
NCT01327352
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +2 more
- Locations
-
- Assaf Harofe Medical Center, Zrifin, Israel
NCT01060410
- Conditions
- Adverse Effects, Autoimmune Diseases, Connective Tissue Diseases, +8 more
- Locations
-
- Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University Guangzhou, Guangdong, China
Completed
Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia
NCT01549184
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +20 more
- Locations
-
Not specified
NCT00668330
- Conditions
- Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
- Locations
-
- School of Pharmacy CUHK Hong Kong, China